Incannex Total Stockholder Equity vs Current Deferred Revenue Analysis

IXHL Stock

USD 1.78 0.04 2.20%

Incannex Healthcare financial indicator trend analysis is infinitely more than just investigating Incannex Healthcare recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Incannex Healthcare is a good investment. Please check the relationship between Incannex Healthcare Total Stockholder Equity and its Current Deferred Revenue accounts. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Incannex Healthcare Ltd. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate.

Total Stockholder Equity vs Current Deferred Revenue

Total Stockholder Equity vs Current Deferred Revenue Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Incannex Healthcare Total Stockholder Equity account and Current Deferred Revenue. At this time, the significance of the direction appears to have almost no relationship.

The correlation between Incannex Healthcare's Total Stockholder Equity and Current Deferred Revenue is 0.15. Overlapping area represents the amount of variation of Total Stockholder Equity that can explain the historical movement of Current Deferred Revenue in the same time period over historical financial statements of Incannex Healthcare Ltd, assuming nothing else is changed. The correlation between historical values of Incannex Healthcare's Total Stockholder Equity and Current Deferred Revenue is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Total Stockholder Equity of Incannex Healthcare Ltd are associated (or correlated) with its Current Deferred Revenue. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Current Deferred Revenue has no effect on the direction of Total Stockholder Equity i.e., Incannex Healthcare's Total Stockholder Equity and Current Deferred Revenue go up and down completely randomly.

Correlation Coefficient

0.15

Relationship Direction	Positive
Relationship Strength	Insignificant

View All Relationships

Total Stockholder Equity

The total equity held by shareholders, calculated as the difference between a company's total assets and total liabilities. It represents the net value of the company owned by shareholders.

Current Deferred Revenue

Revenue that has been collected but not yet earned, typically from prepaid service contracts or subscriptions. This amount is considered a liability until the service is provided or the subscription period ends.

Most indicators from Incannex Healthcare's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Incannex Healthcare current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Incannex Healthcare Ltd. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate.

At this time, Incannex Healthcare's Selling General Administrative is quite stable compared to the past year. Tax Provision is expected to rise to about 31.5 K this year, although the value of Issuance Of Capital Stock will most likely fall to 0.00.

	2021	2022	2023	2024 (projected)
Interest Expense	218.07	3.0K	2.7K	2.6K
Depreciation And Amortization	7.8M	23K	103K	97.9K

Interest Expense Depreciation And Amortization

Incannex Healthcare fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Cash And Short Term Investments	Net Receivables	Common Stock Shares Outstanding	Non Current Liabilities Total	Total Liab	Total Current Assets	Short Term Debt	Common Stock	Other Current Assets	Other Stockholder Equity	Non Currrent Assets Other	Inventory	Current Deferred Revenue	Short Term Investments	Intangible Assets
Total Assets		0.45	0.13	0.29	0.97	0.5	-0.63	-0.3	0.43	0.66	0.5	0.66	0.17	0.46	0.08	0.26	0.65	0.28	0.04	0.1	0.36	0.21	-0.17	0.09	-0.06	0.37
Short Long Term Debt Total	0.45		0.05	0.19	0.29	0.71	0.17	0.13	-0.17	-0.12	0.7	-0.12	-0.13	-0.07	0.46	0.4	-0.12	0.93	0.36	-0.07	-0.19	-0.1	0.19	-0.39	-0.57	-0.19
Other Current Liab	0.13	0.05		0.97	0.06	-0.14	0.04	-0.7	0.0	-0.05	-0.13	-0.05	0.8	-0.08	-0.18	0.79	0.39	0.05	-0.42	0.97	0.66	-0.14	-0.8	0.18	0.2	0.4
Total Current Liabilities	0.29	0.19	0.97		0.21	-0.02	-0.04	-0.71	0.15	0.04	-0.02	0.04	0.74	-0.05	-0.2	0.79	0.46	0.17	-0.41	0.91	0.68	-0.15	-0.73	0.17	0.17	0.38
Total Stockholder Equity	0.97	0.29	0.06	0.21		0.41	-0.72	-0.28	0.48	0.74	0.41	0.74	0.16	0.55	-0.05	0.1	0.7	0.1	0.03	0.05	0.36	0.26	-0.16	0.15	0.05	0.44
Property Plant And Equipment Net	0.5	0.71	-0.14	-0.02	0.41		0.29	0.3	-0.29	-0.25	1.0	-0.26	-0.08	-0.19	0.33	0.13	-0.3	0.77	0.15	-0.21	-0.2	0.44	0.15	-0.35	-0.59	-0.36
Net Debt	-0.63	0.17	0.04	-0.04	-0.72	0.29		0.39	-0.74	-1.0	0.29	-1.0	-0.03	-0.75	0.15	0.08	-0.9	0.42	-0.05	0.0	-0.38	0.09	0.09	-0.37	-0.42	-0.64
Retained Earnings	-0.3	0.13	-0.7	-0.71	-0.28	0.3	0.39		-0.52	-0.38	0.3	-0.38	-0.79	-0.06	0.17	-0.65	-0.7	0.25	0.56	-0.79	-0.95	0.42	0.82	-0.41	-0.53	-0.7
Accounts Payable	0.43	-0.17	0.0	0.15	0.48	-0.29	-0.74	-0.52		0.74	-0.29	0.74	0.06	0.32	-0.23	0.02	0.69	-0.36	-0.29	0.04	0.54	-0.29	-0.1	0.3	0.56	0.47
Cash	0.66	-0.12	-0.05	0.04	0.74	-0.25	-1.0	-0.38	0.74		-0.26	1.0	0.01	0.74	-0.13	-0.06	0.89	-0.37	0.07	-0.01	0.37	-0.09	-0.06	0.34	0.38	0.62
Non Current Assets Total	0.5	0.7	-0.13	-0.02	0.41	1.0	0.29	0.3	-0.29	-0.26		-0.26	-0.09	-0.19	0.33	0.12	-0.3	0.76	0.15	-0.21	-0.2	0.46	0.15	-0.35	-0.59	-0.37
Cash And Short Term Investments	0.66	-0.12	-0.05	0.04	0.74	-0.26	-1.0	-0.38	0.74	1.0	-0.26		0.01	0.74	-0.13	-0.06	0.89	-0.37	0.07	-0.01	0.37	-0.09	-0.06	0.34	0.38	0.61
Net Receivables	0.17	-0.13	0.8	0.74	0.16	-0.08	-0.03	-0.79	0.06	0.01	-0.09	0.01		-0.05	-0.23	0.63	0.42	-0.14	-0.58	0.9	0.81	-0.16	-0.99	0.3	0.41	0.56
Common Stock Shares Outstanding	0.46	-0.07	-0.08	-0.05	0.55	-0.19	-0.75	-0.06	0.32	0.74	-0.19	0.74	-0.05		0.03	-0.14	0.64	-0.24	0.55	-0.07	-0.04	-0.14	0.02	0.26	0.29	0.39
Non Current Liabilities Total	0.08	0.46	-0.18	-0.2	-0.05	0.33	0.15	0.17	-0.23	-0.13	0.33	-0.13	-0.23	0.03		0.39	-0.21	0.54	0.37	-0.21	-0.27	-0.12	0.23	-0.26	-0.45	-0.3
Total Liab	0.26	0.4	0.79	0.79	0.1	0.13	0.08	-0.65	0.02	-0.06	0.12	-0.06	0.63	-0.14	0.39		0.29	0.43	-0.29	0.77	0.58	-0.28	-0.62	0.0	-0.07	0.21
Total Current Assets	0.65	-0.12	0.39	0.46	0.7	-0.3	-0.9	-0.7	0.69	0.89	-0.3	0.89	0.42	0.64	-0.21	0.29		-0.34	-0.18	0.44	0.68	-0.17	-0.47	0.41	0.48	0.78
Short Term Debt	0.28	0.93	0.05	0.17	0.1	0.77	0.42	0.25	-0.36	-0.37	0.76	-0.37	-0.14	-0.24	0.54	0.43	-0.34		0.32	-0.07	-0.28	0.02	0.21	-0.48	-0.72	-0.48
Common Stock	0.04	0.36	-0.42	-0.41	0.03	0.15	-0.05	0.56	-0.29	0.07	0.15	0.07	-0.58	0.55	0.37	-0.29	-0.18	0.32		-0.52	-0.74	-0.16	0.6	-0.17	-0.3	-0.3
Other Current Assets	0.1	-0.07	0.97	0.91	0.05	-0.21	0.0	-0.79	0.04	-0.01	-0.21	-0.01	0.9	-0.07	-0.21	0.77	0.44	-0.07	-0.52		0.76	-0.19	-0.91	0.24	0.3	0.48
Other Stockholder Equity	0.36	-0.19	0.66	0.68	0.36	-0.2	-0.38	-0.95	0.54	0.37	-0.2	0.37	0.81	-0.04	-0.27	0.58	0.68	-0.28	-0.74	0.76		-0.19	-0.83	0.38	0.5	0.68
Non Currrent Assets Other	0.21	-0.1	-0.14	-0.15	0.26	0.44	0.09	0.42	-0.29	-0.09	0.46	-0.09	-0.16	-0.14	-0.12	-0.28	-0.17	0.02	-0.16	-0.19	-0.19		0.15	-0.27	-0.45	-0.29
Inventory	-0.17	0.19	-0.8	-0.73	-0.16	0.15	0.09	0.82	-0.1	-0.06	0.15	-0.06	-0.99	0.02	0.23	-0.62	-0.47	0.21	0.6	-0.91	-0.83	0.15		-0.34	-0.45	-0.6
Current Deferred Revenue	0.09	-0.39	0.18	0.17	0.15	-0.35	-0.37	-0.41	0.3	0.34	-0.35	0.34	0.3	0.26	-0.26	0.0	0.41	-0.48	-0.17	0.24	0.38	-0.27	-0.34		0.65	0.57
Short Term Investments	-0.06	-0.57	0.2	0.17	0.05	-0.59	-0.42	-0.53	0.56	0.38	-0.59	0.38	0.41	0.29	-0.45	-0.07	0.48	-0.72	-0.3	0.3	0.5	-0.45	-0.45	0.65		0.7
Intangible Assets	0.37	-0.19	0.4	0.38	0.44	-0.36	-0.64	-0.7	0.47	0.62	-0.37	0.61	0.56	0.39	-0.3	0.21	0.78	-0.48	-0.3	0.48	0.68	-0.29	-0.6	0.57	0.7

Click cells to compare fundamentals

Incannex Healthcare Account Relationship Matchups

Incannex Healthcare fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	2.9M	7.0M	26.2M	23.8M	17.0M	9.1M
Other Current Liab	330.9K	392.1K	490.1K	689K	4.9M	5.2M
Total Current Liabilities	736.4K	567.3K	1.4M	2.6M	5.6M	5.9M
Total Stockholder Equity	2.2M	6.4M	24.8M	20.8M	11.2M	9.2M
Property Plant And Equipment Net	97.7K	85.4K	0.0	786K	845K	802.8K
Net Debt	(2.5M)	(6.9M)	(25.9M)	(21.6M)	(5.5M)	(5.2M)
Retained Earnings	(22.3M)	(33.0M)	(40.6M)	(92.2M)	(110.7M)	(105.1M)
Accounts Payable	405.5K	175.1K	898.0K	1.7M	527K	525.5K
Cash	2.5M	6.9M	25.9M	22.1M	5.9M	4.5M
Non Current Assets Total	168.7K	134.8K	0.0	786K	845K	802.8K
Cash And Short Term Investments	2.5M	6.9M	25.9M	22.1M	5.9M	4.6M
Net Receivables	284.0K	127.0K	219.3K	256.5K	10.0M	10.5M
Common Stock Shares Outstanding	17.1M	24.5M	297.8M	15.4M	16.2M	25.3M
Liabilities And Stockholders Equity	2.9M	7.0M	26.2M	23.8M	17.0M	12.1M
Non Current Liabilities Total	590.1K	233.1K	1.3M	408K	210K	199.5K
Total Liab	736.4K	567.3K	1.4M	3.0M	5.8M	6.1M
Total Current Assets	2.9M	7.0M	26.2M	23.0M	16.2M	17.0M
Accumulated Other Comprehensive Income	1.0M	3.3M	0.0	(3.3M)	(3.3M)	(3.2M)
Common Stock	23.5M	34.5M	59.5M	2K	2.3K	2.2K
Other Current Assets	17.3K	36.1K	261.3K	877K	10.3M	10.9M
Inventory	125.9K	(178.1K)	(337.5K)	(416.2K)	(10.0M)	(9.5M)
Net Tangible Assets	3.2M	8.6M	35.9M	31.4M	36.1M	37.9M
Net Invested Capital	3.2M	8.6M	52.1M	84.1M	11.2M	10.7M
Net Working Capital	3.2M	8.6M	52.1M	30.8M	10.6M	16.4M
Capital Stock	34.2M	45.9M	125.9M	150.8M	2K	1.9K

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect

When determining whether Incannex Healthcare is a strong investment it is important to analyze Incannex Healthcare's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Incannex Healthcare's future performance. For an informed investment choice regarding Incannex Stock, refer to the following important reports:

How To Invest In Incannex

Details

Is Incannex Stock a good investment?

Details

What is Incannex Healthcare's Net Worth?

Details

Largest Biotechnology Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Incannex Healthcare Ltd. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate.

You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.

Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Incannex Healthcare. If investors know Incannex will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Incannex Healthcare listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(1.36)

Revenue Per Share

0.001

Quarterly Revenue Growth

0.296

Return On Assets

(0.57)

Return On Equity

(1.15)

The market value of Incannex Healthcare is measured differently than its book value, which is the value of Incannex that is recorded on the company's balance sheet. Investors also form their own opinion of Incannex Healthcare's value that differs from its market value or its book value, called intrinsic value, which is Incannex Healthcare's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Incannex Healthcare's market value can be influenced by many factors that don't directly affect Incannex Healthcare's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Incannex Healthcare's value and its price as these two are different measures arrived at by different means. Investors typically determine if Incannex Healthcare is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Incannex Healthcare's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Incannex Total Stockholder Equity vs Current Deferred Revenue Analysis

Total Stockholder Equity vs Current Deferred Revenue

Total Stockholder Equity vs Current Deferred Revenue Correlation Analysis

Correlation Coefficient

Total Stockholder Equity

Current Deferred Revenue

Incannex Healthcare fundamental ratios Correlations

Incannex Healthcare Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Incannex Healthcare fundamental ratios Accounts

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Non Current Assets Total	+ 1.0	Property Plant And Equipment Net
Cash And Short Term Investments	+ 1.0	Cash
Total Stockholder Equity	+ 0.97	Total Assets
Total Current Liabilities	+ 0.97	Other Current Liab
Other Current Assets	+ 0.97	Other Current Liab
Short Term Debt	+ 0.93	Short Long Term Debt Total

Cash And Short Term Investments	- 1.0	Net Debt
Cash	- 1.0	Net Debt
Inventory	- 0.99	Net Receivables
Other Stockholder Equity	- 0.95	Retained Earnings
Inventory	- 0.91	Other Current Assets
Total Current Assets	- 0.9	Net Debt